Survivorship Care for Women Living With Ovarian Cancer: (POSTCARE-O)
This study will enroll 120 women living with ovarian cancer following completion of initial treatment. Our objective is to test an intervention designed to provide support during the survivorship transition for this population, who live with a high degree of morbidity related to the illness and its treatment as well as a high risk of recurrence. Study participants will be randomly assigned to receive survivorship care using the POSTCare-O process or usual care. The primary outcome is quality of life at 12 weeks…
Conditions studied
Ovarian Neoplasm, Depressive Symptoms, Quality of Life
About this study
This study will enroll 120 women living with ovarian cancer following completion of initial treatment. Our objective is to test an intervention designed to provide support during the survivorship transition for this population, who live with a high degree of morbidity related to the illness and its treatment as well as a high risk of recurrence. Study participants will be randomly assigned to receive survivorship care using the POSTCare-O process or usual care. The primary outcome is quality of life at 12 weeks after intervention.
Interventions
- Behavioral: POSTCare Survivorship transition process — Survivorship coaching intervention
Primary outcomes
- Quality of Life by FACT-O (12 Weeks)
Eligibility information
Study locations
- UT Southwestern Parkland Health and Hospital System, Dallas, Texas 75235 United States
- Dan L Duncan Comprehensive Cancer Center at the O'Quinn Medical Tower at Baylor St. Luke's Medical Center, Houston, Texas 77030 United States
- Harris Health Smith Clinic, Houston, Texas 77054 United States
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.